Cargando…
p53 Mutations and c‐erbB‐2 Amplification in Intraductal and Invasive Breast Carcinomas of High Histologic Grade
In order to clarify the clinical significance of mutations of the p53 gene and amplification of the c‐erbB‐2 gene in breast carcinoma, these gene alterations were examined in 101 invasive, seven predominantly intraductal and 10 intraductal breast carcinomas by single‐strand conformation polymorphism...
Autores principales: | Tsuda, Hitoshi, Iwaya, Keiichi, Fukutomi, Takashi, Hirohashi, Setsuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
1993
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919306/ https://www.ncbi.nlm.nih.gov/pubmed/8099903 http://dx.doi.org/10.1111/j.1349-7006.1993.tb00149.x |
Ejemplares similares
-
Different Incidence of Loss of Heterozygosity on Chromosome 16q between Intraductal Papilloma and Intracystic Papillary Carcinoma of the Breast
por: Tsuda, Hitoshi, et al.
Publicado: (1994) -
Nuclear p53 Immunoreaction Associated with Poor Prognosis of Breast Cancer
por: Iwaya, Keiichi, et al.
Publicado: (1991) -
Immunohistochemical Study on Overexpression of c‐erbB‐2 Protein in Human Breast Cancer: Its Correlation with Gene Amplification and Long‐term Survival of Patients
por: Tsuda, Hitoshi, et al.
Publicado: (1990) -
Frequent Occurrence of p53 Gene Mutations in Uterine Cancers at Advanced Clinical Stage and with Aggressive Histological Phenotypes
por: Tsuda, Hitoshi, et al.
Publicado: (1992) -
Histological Factors Associated with Initial Bone Metastasis of Invasive Ductal Carcinoma of the Breast
por: Koyama, Tadaaki, et al.
Publicado: (1999)